Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 2/20 | 0.48 |
| ▸ | CTSK | P43235 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.46 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.46 |
| ▸ | XDH | P47989 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 2/20 | 0.43 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.42 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14224868 | 0.85 | GABRG2 (0.42) | CTSSCTSKIDO1GRM2GABRG2 | |
| SCHEMBL14224889 | 0.83 | GRM5 (0.57) | GRM2GRM5 | |
| SCHEMBL3266995 | 0.79 | IDO1 (0.51) | CTSSCTSKIDO1CLK4XDH | |
| SCHEMBL10431256 | 0.78 | GABRA1 (0.59) | CTSSCTSKIDO1CLK4XDH | |
| SCHEMBL9792980 | 0.77 | CTSS (0.62) | CTSSCTSKIDO1CLK4XDH | |
| SCHEMBL15469175 | 0.77 | MEN1 (0.47) | — | |
| SCHEMBL12836990 | 0.76 | CTSS (0.47) | CTSSCTSKIDO1GRM2CLK4 | |
| SCHEMBL11931991 | 0.76 | MEN1 (0.60) | ADORA2AADORA1 | |
| SCHEMBL901316 | 0.76 | ASIC3 (0.56) | CTSSCTSKIDO1CLK4XDH | |
| SCHEMBL20710587 | 0.75 | XDH (0.49) | CTSSCTSKIDO1CLK4XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8202631-B2 | Light-emitting device | FUJIFILM CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-7732606-B2 | Light-emitting device | FUJIFILM CORPORATION (JP) | 2010-06-08 | — | — | US | disclosed |
| US-20090309490-A1 | LIGHT-EMITTING DEVICE | UDC IRELAND LIMITED (IE) | 2009-12-17 | — | — | US | disclosed |
| US-20080079358-A1 | Organic electroluminescent element | FUJIFILM CORPORATION | 2008-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090309490-A1 | LIGHT-EMITTING DEVICE | L1CAM, LIG1, CD274 | CTSS 3526/4885CTSK 4234/4885IDO1 487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.